SCM
NVO

Sterling Capital Management’s Novo Nordisk NVO Stock Holding History

Sterling Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37M Sell
49,472
-1,127
-2% -$48.4K 0.04% 329
2026
Q1 		$1.86M Buy
50,599
+6,827
+16% +$323K 0.04% 347
2025
Q4 		$2.23M Buy
43,772
+3,664
+9% +$187K 0.04% 359
2025
Q3 		$2.23M Buy
40,108
+4,146
+12% +$243K 0.03% 356
2025
Q2 		$2.48M Buy
35,962
+11,375
+46% +$774K 0.04% 322
2025
Q1 		$1.71M Buy
24,587
+6,110
+33% +$505K 0.03% 411
2024
Q4 		$1.59M Sell
18,477
-1,164
-6% -$126K 0.02% 488
2024
Q3 		$2.34M Buy
+19,641
New +$2.62M 0.03% 346
2019
Q3 		$481K Buy
18,626
+452
+2% +$11.4K ﹤0.01% 760
2019
Q2 		$464K Sell
18,174
-248
-1% -$6.13K ﹤0.01% 765
2019
Q1 		$482K Sell
18,422
-4,168
-18% -$102K ﹤0.01% 753
2018
Q4 		$520K Buy
22,590
+228
+1% +$5.07K 0.01% 736
2018
Q3 		$527K Buy
22,362
+50
+0.2% +$1.22K ﹤0.01% 781
2018
Q2 		$515K Sell
22,312
-678
-3% -$16.1K ﹤0.01% 755
2018
Q1 		$566K Buy
22,990
+402
+2% +$10.6K 0.01% 742
2017
Q4 		$606K Buy
22,588
+30
+0.1% +$763 0.01% 744
2017
Q3 		$543K Buy
22,558
+1,920
+9% +$43.4K 0.01% 755
2017
Q2 		$443K Sell
20,638
-9,436
-31% -$190K ﹤0.01% 789
2017
Q1 		$515K Sell
30,074
-2,748
-8% -$47.8K ﹤0.01% 788
2016
Q4 		$588K Sell
32,822
-47,814
-59% -$867K 0.01% 753
2016
Q3 		$1.68M Buy
80,636
+6,406
+9% +$159K 0.02% 425
2016
Q2 		$2M Buy
74,230
+58,746
+379% +$1.61M 0.02% 388
2016
Q1 		$420K Buy
15,484
+564
+4% +$15.1K ﹤0.01% 775
2015
Q4 		$433K Sell
14,920
-2,316
-13% -$64.1K ﹤0.01% 801
2015
Q3 		$467K Buy
+17,236
New +$488K ﹤0.01% 773

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Sterling Capital Management's NVO Position: Q2 2026 in Review

Sterling Capital Management reduced its Novo Nordisk (NVO) stake by 2.2% in Q2 2026, selling an estimated $48.4K and leaving 49,472 shares worth $2.37M. The position accounts for 0.04% of the portfolio, ranked #329.

Sterling Capital Management first reported a position in NVO in Q3 2015 and has held it in 25 quarters since. The position peaked at $2.48M in Q2 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Sterling Capital Management held 49,472 shares of Novo Nordisk worth $2.37M as of Q2 2026.
  • Sterling Capital Management sold 1,127 Novo Nordisk shares in Q2 2026, an estimated $48.4K.
  • Novo Nordisk made up 0.04% of Sterling Capital Management's portfolio in Q2 2026, its #329 holding.
  • Sterling Capital Management first reported a position in Novo Nordisk in Q3 2015 and has held it in 25 quarters since.
  • Sterling Capital Management's Novo Nordisk position peaked at $2.48M in Q2 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.